#MissionTherapeutics #Dimerix #kidneydisease #renal #Parkinsonsdisease #outlicensing #acutekidneyinjury #biotech #MTX652 #drugcandidate #deubiquitylatingenzymes #DUBs #mitophagy #acutekidneydisease #neurodegenerativediseases #Alzheimers #Huntingtons #amyotrophiclateralsclerosis #ALS
zurl.co/oEToB
zurl.co/oEToB
UK's Mission divests kidney drug to Dimerix for $292m
Mission Therapeutics has struck a deal to out-license a drug for acute kidney injury to Australia's Dimerix, sharpening its focus on CNS diseases.
pharmaphorum.com
July 21, 2026 at 12:31 PM
Thoughts on this? >> Pharma-backed Mission Therapeutics stops preclinical
operations, focuses on two clinical assets: Clinical-stage biotech Mission Therapeutics is closing… >> Comment below! #strategy #competitiveintelligence #marketing #biotech #pharma #productmarketing #healthcare #pharmaceutical
operations, focuses on two clinical assets: Clinical-stage biotech Mission Therapeutics is closing… >> Comment below! #strategy #competitiveintelligence #marketing #biotech #pharma #productmarketing #healthcare #pharmaceutical
Pharma-backed Mission Therapeutics stops preclinical
operations, focuses on two clinical assets
Clinical-stage biotech Mission Therapeutics is closing its preclinical laboratory operations in Cambridge, UK, a spokesperson confirmed to Endpoints News. The biotech will focus on its clinical programs, MTX325 and MTX652, the spokesperson said in an ...
dlvr.it
February 27, 2025 at 8:18 PM
Thoughts on this? >> Pharma-backed Mission Therapeutics stops preclinical
operations, focuses on two clinical assets: Clinical-stage biotech Mission Therapeutics is closing… >> Comment below! #strategy #competitiveintelligence #marketing #biotech #pharma #productmarketing #healthcare #pharmaceutical
operations, focuses on two clinical assets: Clinical-stage biotech Mission Therapeutics is closing… >> Comment below! #strategy #competitiveintelligence #marketing #biotech #pharma #productmarketing #healthcare #pharmaceutical